Treating acute MI [myocardial infarction] patients with Aggrastat [tirofiban] on their way to hospital.
Latest Information Update: 27 Feb 2017
Price :
$35 *
At a glance
- Drugs Tirofiban (Primary)
- Indications Embolism and thrombosis; Myocardial infarction
- Focus Therapeutic Use
- 10 Aug 2011 Planned end date (Jan 2012) added as reported by ClinicalTrials.gov.
- 01 Oct 2006 New trial record.